Remove Marketing Remove Medical Remove Pharmaceutical
article thumbnail

There Are So Many Skincare Lines– Is One Better Than Another?

Renee Rouleau

In today’s saturated skincare market, it can be overwhelming to navigate through the countless options available. Pharmaceutical and Medical Advancements Ingredients that have been traditionally used for non-skincare purposes are now finding their way into the beauty industry. This is a fair point.

Skincare 195
article thumbnail

Weight-loss stocks soar up to 15% after obesity-drug study shows an added benefit that may be a ‘huge win’ for future sales

Aesthetics Advisor

. — better known as Weight Watchers — which bought a telemedicine firm that prescribes obesity medications earlier this year, soared 13%. Analysts saw the benefit extending the market for Wegovy as well as Lilly’s Mounjaro and possibly removing an obstacle in insurance reimbursement. also gained — rising 9.0% respectively.

Sales 36
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

article thumbnail

Sun Pharma Launches WINLEVI CTV Ad Campaign to Demystify Sebum With Dr. Sandra Lee

The Dermatology Digest

Sun Pharmaceutical Industries, Inc. The parents misunderstand this unfamiliar word as inappropriate for family dinner conversation but quickly learn from Dr. Lee that it is a medical term that does not need to be censored. Food and Drug Administration-approved topical acne treatment available in the U.S.

Sebum 36
article thumbnail

Biosimilar News: FDA Approves Simlandi as Third Interchangeable Humira Biosimilar

The Dermatology Digest

While both low-concentration and high-concentration strength biosimilars of Humira are marketed in the U.S. “The approval of SIMLANDI marks the first high-concentration, citrate-free biosimilar to Humira with IC status,” says Dr. Eric Hughes, Executive Vice President Global R&D and Chief Medical Officer at Teva, in a news release.

Safety 36
article thumbnail

TDD Industry News and Views: Weekly Updates on Comings, Goings, and Other Happenings in Dermatology

The Dermatology Digest

Verrica Pharmaceuticals Files Lawsuit Against Canadian Drug Manufacturer for False Advertising, Unfair Competition Verrica Pharmaceuticals Inc. a Canada corporation requesting that the court enjoin Dormer Labs from marketing, selling, and distributing drugs containing cantharidin in the United States.

article thumbnail

Let’s Talk About Sebum: Dr. Pimple Popper Chats With TDD About New Sun Pharma Acne Campaign.

The Dermatology Digest

Sun Pharmaceutical Industries, Inc. Market research confirms my experience as a dermatologist, and what I know from other dermatology practices, in that teenagers don’t want to talk about their acne yet may internalize feelings of shame. The new campaign focuses on the role of sebum as a main cause of acne.

Sebum 36